BNC Korea Co., Ltd. (256840.KQ)

KRW 4160.0

(-1.42%)

Net Income Summary of BNC Korea Co., Ltd.

  • BNC Korea Co., Ltd.'s latest annual net income in 2023 was 25.68 Billion KRW , up 157.46% from previous year.
  • BNC Korea Co., Ltd.'s latest quarterly net income in 2024 Q2 was 296.22 Million KRW , down -88.73% from previous quarter.
  • BNC Korea Co., Ltd. reported an annual net income of -44.7 Billion KRW in 2022, up 74.64% from previous year.
  • BNC Korea Co., Ltd. reported an annual net income of -176.26 Billion KRW in 2021, down -12476.26% from previous year.
  • BNC Korea Co., Ltd. reported a quarterly net income of 2.62 Billion KRW for 2024 Q1, down -74.35% from previous quarter.
  • BNC Korea Co., Ltd. reported a quarterly net income of 25.68 Billion KRW for 2023 FY, up 157.46% from previous quarter.

Annual Net Income Chart of BNC Korea Co., Ltd. (2023 - 2016)

Historical Annual Net Income of BNC Korea Co., Ltd. (2023 - 2016)

Year Net Income Net Income Growth
2023 25.68 Billion KRW 157.46%
2022 -44.7 Billion KRW 74.64%
2021 -176.26 Billion KRW -12476.26%
2020 1.42 Billion KRW 126.37%
2019 -5.4 Billion KRW -330.63%
2018 2.34 Billion KRW 2105.41%
2017 106.18 Million KRW 993.92%
2016 -11.87 Million KRW 0.0%

Peer Net Income Comparison of BNC Korea Co., Ltd.

Name Net Income Net Income Difference
HLB Pharmaceutical Co., Ltd -19.42 Billion KRW 232.215%
CMG Pharmaceutical Co., Ltd. 6.45 Billion KRW -297.904%
Celltrion Pharm, Inc. 21.26 Billion KRW -20.79%
Huons Global Co., Ltd. 38.38 Billion KRW 33.081%
DongKook Pharmaceutical Co., Ltd. 47.17 Billion KRW 45.552%
Enzychem Lifesciences Corporation -9.32 Billion KRW 375.412%
Humedix Co., Ltd. 24.82 Billion KRW -3.487%
Boditech Med Inc. 25.94 Billion KRW 1.004%
EuBiologics Co., Ltd. -13.87 Billion KRW 285.072%
FutureChem Co.,Ltd -6.7 Billion KRW 482.863%
Huons Co., Ltd. 50.47 Billion KRW 49.109%
AptaBio Therapeutics Inc. -12.06 Billion KRW 312.957%